2017 IARS Mentored Research Award

Jamie Privratsky, MD, PhD
Assistant Professor of Anesthesiology, Duke University

Dr. Privratsky’s Research

The role of macrophage IL-1 signaling in acute kidney injury and recovery

Acute kidney injury (AKI) dramatically increases morbidity and mortality and is one of the most common forms of organ failure in perioperative and critically ill patients. Unresolved AKI leads to ongoing renal injury, fibrosis, and subsequent chronic kidney disease (CKD), which is a major risk factor for future cardiovascular events. The mechanisms that direct renal recovery after AKI and prevent the AKI to CKD transition are poorly understood. Based on preliminary data, our central hypothesis is that IL-1R1 activation sustains detrimental macrophage polarization to drive AKI and promote the AKI to CKD transition, culminating in kidney fibrosis. Our specific aims are as follows:

Specific Aim 1: Determine effects of IL-1R1 signaling on renal macrophage polarization during AKI. Mice with macrophage-specific deletion of IL-1R1 (IL-1R1 MKO) and controls will be subjected to ischemia/reperfusion (I/R)-induced AKI. We will measure the severity of kidney damage, assess the polarization of infiltrating macrophages via fluorescent cell sorting and RT-PCR, and characterize injury in renal tubular cells following co-culture with isolated WT and IL-1R1 MKO macrophages from injured kidneys.

Specific Aim 2: Determine effects of IL-1R1 signaling on the development of renal fibrosis following AKI. We will subject IL-1R1 MKO mice and littermate controls to I/R-induced AKI and 28 days later examine the extent of kidney fibrosis. At multiple timepoints, intra-renal macrophages will be phenotyped by fluorescent cell sorting and analyzed for pro-inflammatory and pro-fibrotic gene expression by RNAseq. The capacity of a commercially available IL-1R1 antagonist to alter macrophage polarization and prevent renal fibrosis following AKI will be tested.
These studies should underpin the development of novel immunomodulatory therapies for AKI, which will have a significant positive impact on perioperative and critically ill patients.

Encourage, stimulate, and fund ongoing anesthesia-related research projects that will enhance and advance the specialty, and to disseminate current, state-of-the-art, basic and clinical research data in all areas of clinical anesthesia, including perioperative medicine, critical care, and pain management. The IARS is focused solely on the advancement and support of education and scientific research related to anesthesiology.
A&A
OpenAnesthesia
A&A Case Reports
SmartTots

2019 Annual Meeting

The 2019 IARS Annual Meeting and International Science Symposium will be aligned with the Society of Critical Care Anesthesiologists (SOCCA) and Association of University Anesthesiologists (AUA) Annual Meetings, May 16 – May 20, 2019 at the Fairmont The Queen Elizabeth Hotel in Montreal, Quebec, Canada.

Support IARS

The IARS contributes more than $1 million each year to fund important anesthesia research. Your donation will help support innovative and forward-thinking anesthesia research and education initiatives, all of which are designed to benefit patient care. You can feel good knowing that 100% of your donation is directly allocated to research.